Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study

Phase

N/A

Condition

Attention Deficit/hyperactivity Disorder (Adhd - Adults)

Treatment

MomMA Intervention

Clinical Study ID

NCT06540547

STUDY23100082

Ages 18-55
Female

Study Summary

The study will develop and test a behavioral program for pregnant individuals with Attention-Deficit/Hyperactivity Disorder (ADHD). This behavioral program will include skills for managing ADHD and related symptoms during pregnancy and after delivery and will be taught by a behavioral therapist in OB care settings.

Eligibility Criteria

Inclusion

Inclusion Criteria:

(1) meet full DSM-5 criteria for ADHD
(2) are between 20- and 32-weeks of gestation
(3) speak English
(4) will deliver at the University of Pittsburgh Medical Center (UPMC) Magee Women'sHospital (MWH)

Exclusion

Exclusion Criteria:

(1) active substance use disorder
(2) intellectual disability
(3) other severe mental illness, including bipolar disorder, psychosis, and majordepressive disorder with suicidal ideation or requiring higher level of care (inpatient or partial/intensive outpatient)
(4) high risk pregnancies requiring transfer of care to Maternal-Fetal Medicine (e.g., maternal cancer, multiples, placenta accreta) and/or fetus known to have asevere congenital condition.

Study Design

MomMA Intervention

January 19, 2025

December 31, 2025

Study Description

Treating pregnant individuals with ADHD may improve parent and child wellbeing, parent-child interactions, and psychosocial familial factors to enhance family resilience and reduce prevalence/severity of child mental health disorders. Using the information provided from stakeholder interviews and adaptations of an existing CBT intervention for parents of children with ADHD, the current study will develop the MomMA (Moms Managing ADHD) intervention and implement it via an open clinical trial (n=10 pregnant individuals), delivered by masters-level women's health behavioral therapists. Investigators will examine treatment acceptability, feasibility, and appropriateness, as well as implementation factors (fidelity, adherence, facilitators/barriers) and qualitative data (e.g., feedback interviews). In addition, quantitative data (self-reported symptoms, parenting, and home environment measures; observed parent and child behavior; parent reported child temperament/behavior) will be used to assess parent and child outcomes following the intervention. This mixed-methods model will offer a comprehensive examination of the MomMA intervention and inform a refined intervention model.

Connect with a study center

UPMC Magee Women's Hospital
Pittsburgh, Pennsylvania 15213
United States
Active - Recruiting
University of Pittsburgh
Pittsburgh, Pennsylvania 15213
United States
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.